The paradoxical effect of bevacizumab in the therapy of malignant gliomas.

Published

Journal Article (Letter)

Full Text

Duke Authors

Cited Authors

  • Chamberlain, MC

Published Date

  • August 23, 2011

Published In

Volume / Issue

  • 77 / 8

Start / End Page

  • 803 -

PubMed ID

  • 21860011

Pubmed Central ID

  • 21860011

Electronic International Standard Serial Number (EISSN)

  • 1526-632X

Digital Object Identifier (DOI)

  • 10.1212/WNL.0b013e3182247068

Language

  • eng

Conference Location

  • United States